# Website Ready Synthesis on Orthoptics and Pediatric Eye Care

All source links are carried by the citations in the **Source** column and narrative paragraphs, rather than shown as raw URLs.

## Reconciled baseline

### Clean per-capita comparison for the site

| Country | Reconciled orthoptist count to use | Per 100,000 population | What is being counted | Best site-ready source |
|---|---:|---:|---|---|
| **United States** | **Under 400** | **<0.12** | AACO/AOC’s broad estimate of practicing certified orthoptists; not a licensure registry | UK/Australia vs US module fileciteturn0file2L9-L15 |
| **United Kingdom** | **1,805** | **2.61** | HCPC-registered orthoptists; statutory register count, not just NHS full-time staff | UK/Australia vs US module fileciteturn0file2L9-L15 |
| **Australia** | **1,055** | **4.1** | Workforce estimate summarized from AIHW-linked sources; not a statutory licensure register | UK/Australia vs US module fileciteturn0file2L9-L15 |

The total-population comparison is the cleanest one to lead with on the site. Child-specific cross-country denominators in the research outputs are not fully harmonized: the U.S. uses **under 18**, the UK uses **under 16**, and Australia uses **age 0–14**. That makes the child-rate comparison directionally useful but less clean for a hero claim. The total-population comparison is still stark: even using the U.S. upper-bound estimate, the UK has about **22 times** the U.S. orthoptic workforce per capita, and Australia about **34 times**. fileciteturn0file2L9-L15

### Reconciliation choices and conflict notes

| Item | Keep for the site | Why this is the better figure | Footnote |
|---|---|---|---|
| **U.S. orthoptist workforce** | **Under 400 practicing orthoptists** | It is the direct active-workforce estimate used in the cross-country comparison. The **440 AACO members** figure is best treated as a membership/registration proxy, not an audited active-practice census. | See note A. |
| **U.S. orthoptic training programs** | **17 currently accepting students** | This is the more operational pipeline figure. | See note B. |
| **UK orthoptist workforce** | **1,805 registered orthoptists** | This is the figure used in the dedicated international-comparison module, which was built specifically to normalize cross-country counts. | See note C. |
| **U.S. pediatric ophthalmologists** | **1,060 listed clinicians in April 2023** | It is the latest directory-based national headcount. It should be paired, when needed, with the narrower **800–900 active surgical** estimate as a definitional caveat. | See note D. |
| **CHLA annual volume** | **Nearly 17,000 visits and more than 1,400 surgeries** | It is the later provider-sheet figure and supersedes the earlier brochure figure of **more than 14,000 visits** and **more than 1,300 surgeries**. | See note E. |

**Note A.** One module uses **“under 400”** as the best public active-workforce estimate, while another notes that **all 440 registered AACO members** were surveyed in 2022. Those are not the same denominator: one is an active-practice estimate, the other a membership/registration frame. For site copy, use **under 400 practicing orthoptists** and reserve **440** for a “why the data are thin” sidebar. fileciteturn0file2L21-L25 fileciteturn0file6L15-L18 fileciteturn0file6L51-L52

**Note B.** U.S. program counts conflict across the modules: **17 currently accepting students**, **18 named on a live list**, and **16 established programs** in a 2023 trade-source snapshot. For the site, use **17 current programs** and note elsewhere that the public program inventory itself is inconsistent. fileciteturn0file2L38-L43 fileciteturn0file6L17-L24 fileciteturn0file1L43-L46

**Note C.** The UK count conflicts across modules: **1,805** in the cross-country module and **1,589** in the U.S.-profession module, both attributed to HCPC. Because the cross-country module is explicitly normalized for international comparison, keep **1,805** in the site baseline and flag the alternative in an internal note rather than on the public-facing card. fileciteturn0file2L11-L15 fileciteturn0file6L45-L46 fileciteturn0file6L61-L65

**Note D.** The pediatric-ophthalmology supply literature is describing different universes. **1,056** and **1,060** are directory-based headcounts in 2022 and 2023; **800–900** is a narrower estimate of clinicians actively providing surgical pediatric ophthalmology care. They are not interchangeable. Use **1,060** for “listed national supply” and **800–900** for “active surgical workforce.” fileciteturn0file1L15-L25 fileciteturn0file1L62-L64

**Note E.** CHLA’s more recent materials report **nearly 17,000 visits and more than 1,400 surgeries**, while earlier materials reported **more than 14,000 visits and more than 1,300 surgeries**. That looks like time drift, not contradiction. Use the higher, later figure. fileciteturn0file5L40-L45

## Tier 1 hero stats

| Value | Caption | Scope | Year | Source | Confidence |
|---|---|---|---|---|---|
| **<0.12 vs 2.61 vs 4.1 per 100,000** | The U.S. orthoptist workforce is tiny compared with the UK and Australia | U.S. vs UK vs Australia; total-population comparison | 2021–2026 sources, country-specific | Cross-country comparison module fileciteturn0file2L5-L15 | **[Estimate]** |
| **90.2%** | U.S. counties with **no** pediatric ophthalmologist | United States counties | 2023 | Pediatric workforce module fileciteturn0file1L20-L24 | **[Measured]** |
| **1 in 7** | U.S. children living more than 60 minutes from pediatric ophthalmology care | United States children | 2025 publication | Pediatric workforce module fileciteturn0file1L23-L25 | **[Measured]** |
| **29.8%** | Average pediatric ophthalmology and strabismus fellowship vacancy rate | U.S. fellowship cycles | 2016–2024 | Pediatric workforce module fileciteturn0file1L25-L30 | **[Measured]** |
| **Nearly 17,000 visits and >1,400 surgeries** | Annual CHLA Vision Center throughput | CHLA Vision Center | FY22-era provider sheet | CHLA/USC module fileciteturn0file5L40-L45 | **[Measured]** |
| **18% vs 10%** | Lifetime risk of bilateral visual impairment in people with amblyopia vs those without | Rotterdam Study modeled life-table | Published 2007 | Untreated-consequences module fileciteturn0file0L11-L14 | **[Modeled]** |

## Tier 2 section stats

### The profession

| Value | Caption | Scope | Year | Source | Confidence |
|---|---|---|---|---|---|
| **Under 400** | Estimated practicing orthoptists in the United States | U.S. profession-wide | 2026 public-facing estimate | Cross-country module fileciteturn0file2L21-L25 | **[Low-confidence]** |
| **17** | U.S. orthoptic programs currently accepting students | United States | 2026 | Cross-country module fileciteturn0file2L38-L43 | **[Measured]** |
| **24 months** | Standard U.S. orthoptic training length | U.S. AOC-accredited programs | Current standard | U.S. profession module fileciteturn0file6L17-L20 | **[Measured]** |
| **Likely only teens of graduates per year** | Inferred national orthoptic output | United States | 2025–2026 public program info | U.S. profession module fileciteturn0file6L21-L25 | **[Estimate]** |
| **13 job postings in 6 months** | Visible shortage signal in a very small field | AACO job board snapshot | Jan–Jun 2026 | U.S. profession module fileciteturn0file6L24-L26 | **[Measured]** |

### The need

| Value | Caption | Scope | Year | Source | Confidence |
|---|---|---|---|---|---|
| **2.5% to 2.6%** | Preschool strabismus prevalence | U.S. population-based preschool cohorts | 2008–2009 publications | Burden-and-funnel module fileciteturn0file4L17-L20 | **[Measured]** |
| **1.8% to 2.6%** | Preschool amblyopia prevalence range | U.S. population-based preschool cohorts | 2008–2013 publications | Burden-and-funnel module fileciteturn0file4L21-L26 | **[Measured]** |
| **≈557,964** | Estimated U.S. preschoolers with strabismus today | U.S. children ages 0–5 | 2025 modeled denominator | Burden-and-funnel module fileciteturn0file4L19-L20 | **[Estimate]** |
| **≈401,734 to 580,282** | Estimated U.S. preschoolers with amblyopia today | U.S. children ages 0–5 | 2025 modeled denominator | Burden-and-funnel module fileciteturn0file4L24-L26 | **[Estimate]** |
| **5.0%** | Preschoolers screening positive for amblyopia risk factors | 16 U.S. photoscreening programs | Review published 2017 | Burden-and-funnel module fileciteturn0file4L27-L29 | **[Measured]** |
| **850,000 visits/year** | Diplopia-related ambulatory and ED visits | United States, all ages | 2003–2012 nationally representative visit data; article 2017 | Burden-and-funnel module fileciteturn0file4L64-L65 | **[Measured]** |

### The gap

| Value | Caption | Scope | Year | Source | Confidence |
|---|---|---|---|---|---|
| **61%** | School-age children screened within the prior 2 years | U.S. school-age children | 2021 | Burden-and-funnel module fileciteturn0file4L106-L109 | **[Measured]** |
| **30%** | Of screened children, those referred for an eye exam | Same survey pathway | 2021 | Burden-and-funnel module fileciteturn0file4L106-L109 | **[Measured]** |
| **16.8%** | Net share of all school-age children who were screened, referred, and seen in the survey-defined pathway | U.S. school-age children | 2021 | Burden-and-funnel module fileciteturn0file4L106-L109 | **[Estimate]** |
| **~40%** | Vision screening rate at age 3 | U.S. children age 3 | 2017 evidence base | Burden-and-funnel module fileciteturn0file4L115-L119 | **[Measured]** |
| **~59%** | Completed follow-up exam after preschool referral | Preschool referral follow-up | 2016 study | Burden-and-funnel module fileciteturn0file4L115-L119 | **[Measured]** |
| **46 days vs 14 days** | Median appointment wait, Medicaid vs private | North Carolina pediatric eye-care access study | 2026 | Burden-and-funnel module fileciteturn0file4L144-L146 | **[Measured]** |
| **28.4% vs 10.3%** | Immediate loss to follow-up after amblyopia diagnosis, Medicaid vs private insurance | One U.S. academic-center study | 2015–2018 diagnoses; published 2022 | CHLA-comparison module fileciteturn0file3L64-L66 | **[Measured]** |

### LA and CHLA

| Value | Caption | Scope | Year | Source | Confidence |
|---|---|---|---|---|---|
| **~12,741 to ~13,272** | Estimated LA County preschoolers with strabismus | Los Angeles County children ages 6–72 months | 2024 denominator applied to MEPEDS prevalence | CHLA/USC module fileciteturn0file5L14-L19 | **[Estimate]** |
| **~5,117 to ~8,869** | Estimated LA County preschoolers with amblyopia | Los Angeles County children ages 30–72 months | 2024 denominator applied to MEPEDS prevalence | CHLA/USC module fileciteturn0file5L17-L19 | **[Estimate]** |
| **47.7%** | LA County children covered by Medi-Cal | Los Angeles County children ages 0–17 | 2018–2022 ACS as reported in CHLA CHNA | CHLA/USC module fileciteturn0file5L29-L33 | **[Measured]** |
| **71.2% and 60.7%** | Child Medi-Cal coverage in the highest-burden SPAs | SPA 6 South and SPA 4 Metro | 2018–2022 ACS as reported in CHLA CHNA | CHLA/USC module fileciteturn0file5L29-L31 | **[Measured]** |
| **Over 20 clinicians** | Combined ophthalmologists, optometrists, and orthoptists on the CHLA Vision Center team | CHLA Vision Center | Current page | CHLA/USC module fileciteturn0file5L40-L43 | **[Measured]** |
| **~8,109 visits and ~668 surgeries** | Conservative lower-bound estimate of CHLA Medi-Cal-linked eye care if the center matched county child coverage | CHLA Vision Center | Modeled from FY22 volume and county child Medi-Cal share | CHLA/USC module fileciteturn0file5L47-L49 | **[Estimate]** |

### The comparison

| Value | Caption | Scope | Year | Source | Confidence |
|---|---|---|---|---|---|
| **3 fellowship positions** | Boston Children’s pediatric ophthalmology fellowship size | Boston Children’s | Current AUPO listing | CHLA-comparison module fileciteturn0file3L19-L23 | **[Measured]** |
| **6 named orthoptists plus the chief orthoptist** | Publicly visible Boston orthoptics depth | Boston Children’s fellowship materials | 2025–2026 pages | CHLA-comparison module fileciteturn0file3L19-L23 | **[Measured]** |
| **22 attendings, 5 optometrists, 2 orthoptists** | CHOP team composition | CHOP Division of Ophthalmology | 2026 page | CHLA-comparison module fileciteturn0file3L19-L23 | **[Measured]** |
| **2 pediatric ophthalmologists and 2 orthoptists** | Publicly visible pediatric team in San Antonio comparator market | Children’s Eye Center of South Texas | 2026 page | CHLA-comparison module fileciteturn0file3L23-L25 | **[Measured]** |
| **1 named board-certified pediatric ophthalmologist** | Thin visible pediatric footprint in one El Paso comparator | One El Paso practice | 2026 page | CHLA-comparison module fileciteturn0file3L57-L58 | **[Measured]** |

### The structural paradox

| Value | Caption | Scope | Year | Source | Confidence |
|---|---|---|---|---|---|
| **CPT 92060 and 92065** | Orthoptic work exists in billable ophthalmic workflow | U.S. orthoptist clinics | Current AOC/AAPOS guidance | U.S. profession module fileciteturn0file6L27-L30 | **[Measured]** |
| **General supervision** | Medicare-level supervision standard for 92060 and 92065 under ophthalmologist oversight | United States | AAPOS policy cited as current public guidance | U.S. profession module fileciteturn0file6L28-L30 | **[Measured]** |
| **41,300** | O*NET “Orthoptists” employment figure is unusable as a true orthoptist count because it comes from a broad residual occupation | United States | 2024 | Pediatric workforce module fileciteturn0file1L47-L47 | **[Low-confidence]** |
| **>$70,000** | Revenue gain from adding a second certified orthoptist in one U.S. practice | Single pediatric ophthalmology practice | 6 months; published 2015 | Pediatric workforce module fileciteturn0file1L48-L50 | **[Measured]** |

### The workforce crisis

| Value | Caption | Scope | Year | Source | Confidence |
|---|---|---|---|---|---|
| **1,060 listed vs ~800–900 active surgical** | Pediatric-ophthalmology supply depends on how you count | United States | 2023 directory count; 2025 review estimate | Pediatric workforce module fileciteturn0file1L20-L25 | **[Measured] / [Estimate]** |
| **72% to 47%** | Share of fellowship positions filled by U.S. graduates fell sharply | U.S. PO&S fellowships | 2016 vs 2024 | Pediatric workforce module fileciteturn0file1L26-L28 | **[Measured]** |
| **24 years** | Median years in practice among pediatric ophthalmologists | U.S. pediatric ophthalmologists in AAPOS-based database | 2022 analysis, published 2023 | Pediatric workforce module fileciteturn0file1L40-L42 | **[Measured]** |
| **23 states** | States flagged high-risk in the most aggressive retirement model | U.S. states | 2023 modeling study | Pediatric workforce module fileciteturn0file1L40-L42 | **[Modeled]** |
| **3.9 months** | Mean new-patient wait at academic eye centers and children’s hospitals | United States | 2023 study | Pediatric workforce module fileciteturn0file1L37-L39 | **[Measured]** |
| **57.1%** | Mean Medicaid share at those academic centers | United States | 2023 study | Pediatric workforce module fileciteturn0file1L37-L39 | **[Measured]** |

### The human stakes

| Value | Caption | Scope | Year | Source | Confidence |
|---|---|---|---|---|---|
| **2.6** | Relative risk of bilateral visual impairment in people with amblyopia vs those without | Rotterdam Study adults 55+ | Published 2007 | Untreated-consequences module fileciteturn0file0L11-L14 | **[Measured]** |
| **32% vs 14%** | Anxiety prevalence in adults with strabismus vs controls | NIH All of Us cohort | Published 2024 | Untreated-consequences module fileciteturn0file0L15-L17 | **[Measured]** |
| **33% vs 14%** | Depression prevalence in adults with strabismus vs controls | NIH All of Us cohort | Published 2024 | Untreated-consequences module fileciteturn0file0L15-L17 | **[Measured]** |
| **73%** | Successful-or-improved rate after office-based CI therapy | Children 9–17 with symptomatic convergence insufficiency | Trial published 2008 | Untreated-consequences module fileciteturn0file0L27-L30 | **[Measured]** |
| **$5.7B to $10B yearly** | Estimated economic burden of children’s vision disorders | United States | 2013 dollars / circa 2019 broader estimate | Burden-and-funnel module fileciteturn0file4L148-L150 | **[Estimate]** |

## Story arc

**Orthoptics is a small profession, but not a small capability.** In the United States, orthoptics sits in the low hundreds, not the thousands, and the training pipeline appears to produce only the teens of graduates per year. Yet the profession is built for high-skill delegation in exactly the parts of ophthalmology where precise measurement, binocular-vision expertise, and standardized follow-up matter most: strabismus, amblyopia, diplopia, convergence and accommodative dysfunction, and neuro-ophthalmic visual assessment. That means orthoptics is not niche because the work is trivial. It is niche because the profession is underbuilt. fileciteturn0file6L5-L9 fileciteturn0file6L15-L25

**The conditions orthoptists help manage are common and consequential.** U.S. preschool strabismus prevalence runs around **2.5% to 2.6%**, preschool amblyopia around **1.8% to 2.6%**, and amblyopia risk factors around **5.0%**. At current population size, that means roughly **0.56 million** preschoolers may have strabismus, **0.4 to 0.6 million** may have amblyopia, and more than **1.1 million** may already be sitting in the upstream risk pool. The burden is not confined to children: adult-onset strabismus has an estimated **1 in 25 lifetime risk**, and diplopia already drives about **850,000 U.S. visits per year**. fileciteturn0file4L17-L31 fileciteturn0file4L61-L65 fileciteturn0file4L128-L136

**The central public-health problem is not just disease burden; it is attrition.** The evidence assembled across the modules shows a care funnel that narrows early and leaks repeatedly. Screening at age 3 is only about **40%**. In the 2021 school-age pathway, **61%** were screened, **30%** of the screened were referred, and **92%** of those referred were seen, which works out to only **16.8%** of all school-age children reaching the survey-defined “screened, referred, and seen” end point. Preschool follow-up after failed screening sits around **59%**, and Medicaid-insured children encounter sharper leakage through longer waits, lower appointment success, and more loss to follow-up. fileciteturn0file4L106-L124 fileciteturn0file4L126-L146

**Los Angeles is a concrete case of why this matters.** LA County likely has roughly **12.7k to 13.3k** preschool children with strabismus and about **5.1k to 8.9k** with amblyopia, while almost **47.7%** of county children are covered by Medi-Cal and some SPAs rise above **60% to 70%**. This is what a large pediatric-eye burden looks like when it is braided with safety-net dependence and neighborhood access inequality. CHLA matters in that setting because it is one of the few institutions built to convert high need into actual specialty throughput at scale. fileciteturn0file5L14-L19 fileciteturn0file5L29-L35 fileciteturn0file5L91-L97

**CHLA and its USC affiliation are a flagship response, not just a local clinic.** The Vision Center reports nearly **17,000 visits** and more than **1,400 surgeries** a year, has **over 20 clinicians**, and describes orthoptists as part of its in-house precision-diagnosis model. Its USC linkage adds fellowship training, faculty appointments, and research capability on top of service capacity. In practical terms, CHLA is a throughput engine, a training site, and a regional referral sink for complexity. fileciteturn0file5L40-L49 fileciteturn0file5L71-L77

**The metro comparison clarifies what a CHLA-class center is worth.** In higher-resource metros such as Boston, Philadelphia, Houston, Cincinnati, and Los Angeles, the visible pattern is not just “more doctors.” It is multidisciplinary depth, orthoptists embedded in the workflow, fellowship pipelines, and published pediatric volume. Lower-resource comparators such as San Antonio, El Paso, and Las Vegas still have pediatric eye care, but the public footprint looks thinner, more fragmented, and less clearly anchored by a high-volume children’s-hospital eye program. The research outputs are careful here: the evidence is stronger for a **system-capacity advantage** than for a clean metro-by-metro clinical-outcomes advantage. fileciteturn0file3L11-L25 fileciteturn0file3L71-L79

**The U.S. structural paradox is that orthoptic work exists, but the workforce does not exist in the system’s line of sight.** CPT-based orthoptic work is real, and AAPOS/AOC materials explicitly frame orthoptists as physician extenders. But the U.S. profession lacks the clean licensure, registration, and workforce visibility that the UK and, to a lesser extent, Australia have. The result is that orthoptic labor is clinically useful but administratively faint: undercounted, hard to model, and weakly legible in reimbursement and workforce planning. That is why the U.S. can have billable orthoptic tasks and still end up with a profession that looks invisible in federal labor data. fileciteturn0file6L27-L30 fileciteturn0file2L80-L90 fileciteturn0file1L47-L48

**At the same time, the pediatric-ophthalmology workforce is strained, uneven, and aging.** Depending on definition, the U.S. has about **1,060 listed pediatric ophthalmologists** or perhaps only **800–900** actively providing surgical pediatric ophthalmology care. **90.2%** of counties have none. About **1 in 7** U.S. children live more than an hour away. Fellowship positions have had a **29.8%** average vacancy rate from 2016 through 2024, the U.S.-graduate fill share fell from **72% to 47%**, and pediatric ophthalmologists already show a retirement-risk profile, with a median of **24 years in practice** and **23 states** flagged high-risk in the most aggressive retirement model. Under-used orthoptic leverage becomes more urgent in exactly that environment. fileciteturn0file1L15-L28 fileciteturn0file1L40-L42 fileciteturn0file1L62-L78

**The human cost is why the rest matters.** Untreated or undertreated amblyopia is associated with a higher lifetime risk of bilateral visual impairment, and strabismus carries measurable psychosocial burden, including sharply higher anxiety and depression in adults. Treatment can restore function and quality of life, but only if patients actually get through the funnel early enough and stay in care. The site should therefore frame orthoptics not as a boutique allied profession, but as a leverage point inside a larger story about vision, school, mobility, mental health, employability, and long-term independence. fileciteturn0file0L11-L17 fileciteturn0file0L54-L62

## Visualization suggestions

| Major stat or comparison | Best chart type | Why it fits |
|---|---|---|
| U.S. vs UK vs Australia orthoptists per 100,000 | **Clustered horizontal bar chart** | Cleanest way to show the order-of-magnitude workforce gap without overcomplicating denominators |
| Under 400 U.S. orthoptists vs 1,805 UK vs 1,055 Australia | **Pictogram or scaled icon row** | Strong for homepage storytelling because the profession is so small in absolute U.S. terms |
| 90.2% of U.S. counties with no pediatric ophthalmologist | **County choropleth plus inset summary bar** | Makes the access-desert point immediately visible |
| 1 in 7 children outside 60 minutes from care | **National service-area map or dumbbell map** | Better than a single number for showing geographic access cliffs |
| 61% screened → 30% referred → 92% seen → 16.8% net throughput | **Funnel chart** | This is exactly a funnel problem; the visual metaphor matches the mechanism |
| Medicaid wait/access gaps | **Side-by-side bars or lollipop chart** | Best for showing 46 vs 14 days and 56% vs 100% in one glance |
| Fellowship vacancy rate and U.S.-graduate fill share | **Dual-line chart** | Lets the audience see persistent under-fill and declining domestic replacement together |
| CHLA annual visits and surgeries | **Big-number stat card + paired bars** | Works well for a flagship-center section because the throughput story is the point |
| LA County burden estimates for strabismus, amblyopia, hyperopia, astigmatism | **Stacked or grouped bars** | Makes it obvious that the upstream refractive-risk pool is much larger than the identified amblyopia pool |
| Higher-resource vs lower-resource metros | **Ranked comparison strip** | A simple metro card grid or ranked strip avoids false precision while still showing the ecosystem gap |
| Mental-health burden in strabismus | **Paired bars** | 32% vs 14% anxiety and 33% vs 14% depression are more powerful than prose |
| Orthoptist-led efficiency results | **Before/after bars** | Best for time-per-visit, cost-per-visit, and waiting-list reduction claims |

## Confidence and gaps

The strongest parts of the evidence base are the **size of the U.S.-versus-UK/Australia workforce gap**, the **thin and geographically uneven U.S. pediatric-ophthalmology supply**, the **weak pediatric-ophthalmology fellowship pipeline**, the **large upstream burden of amblyopia/strabismus risk**, and the **fact that access leakage occurs before diagnosis and treatment completion**. CHLA’s role as a flagship regional center is also well established at the level of volume, multidisciplinary breadth, and institutional structure. fileciteturn0file2L5-L15 fileciteturn0file1L15-L28 fileciteturn0file4L5-L9 fileciteturn0file5L40-L49

The thinnest parts are the ones the site should not overclaim: there is **no clean public U.S. orthoptist census**, **no robust county-by-county orthoptist map**, **no single national dataset that follows children from screening through final visual outcome**, and **no strong U.S. metro-vs-metro outcomes literature proving that a CHLA-class center causes better amblyopia or strabismus outcomes**. There are also unresolved internal discrepancies in public workforce counting, especially around the UK orthoptist total and the exact count of U.S. orthoptic programs. Those are not reasons to soften the argument; they are part of the argument. The scarcity of clean U.S. orthoptics data is itself evidence that the profession remains under-institutionalized here. fileciteturn0file6L67-L76 fileciteturn0file3L81-L90 fileciteturn0file4L158-L166 fileciteturn0file1L96-L101